Plant Health Care Underlying growth prospects are as strong as ever

Plant Health Care (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today provided the following update on trading in 2019.

Chris Richards, CEO of Plant Health Care noted: “In 2019, as in 2018, last minute customer and logistical issues will result in revenue falling short of expectation.  However, the delay in sales is principally a matter of phasing.  Underlying growth prospects are as strong as ever.  The Board intends to address sales phasing during 2020, which will make it easier for investors to track revenue growth.  Costs are under tight control and we recently received a capital injection, so are well positioned to capitalize on the shift of revenue into the next financial year.”

Key points:

·    Due to external factors, year end revenue is expected to be approximately $6.5m, which is short of expectation. This is primarily due to:

o Supply of H2Copla to satisfy demand of $1.1M in sugarcane has been delayed until import licences are granted by the Brazilian authorities.

o Forecast sales of around $1M of Harpin 𝜶β for corn seed in USA have been postponed by our channel partner as they respond to working capital pressures after an exceptionally difficult year.

·    Underlying market demand remains strong, and other parts of the Company’s operations are unaffected.

·    Progress towards the first launches of products from PREtec (Plant Response Elicitor Technology) continues to be very promising, targeting markets worth more than $5 billion.

·    Following the recent fund-raise, the Company is well capitalised to manage the shift of revenue into the next financial year.

Prospects:

·    Prospects for Brazilian sugarcane remain strong, and we expect import licences to be granted early in the New Year. Bureaucratic difficulties are not uncommon for new companies operating in Brazil.

·    After the successful 2019 launch of Harpin 𝜶β into US corn, and enthusiasm from distributor and growers, treated areas in 2020 are still expected to be a multiple of those in 2019; we also expect to see first sales into new crops.

·    As a result of tight control of our operational costs, cash burn in 2019 will be significantly lower than in 2018.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Plant Health Care Plc

    More articles like this

    Plant Health Care Plc

    Plant Health Care appoint new Board directors

    Plant Health Care (LON:PHC) has announced three new Board appointments with effect from 1st November 2019. Mr Guy van Zwanenberg FCA will join the PHC Board as a Non-executive Director. He will take over as Chair of the

    Plant Health Care Plc

    Plant Health Care Progress with PREtec field trials in Brazil

    Plant Health Care (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, has today provided the following update in relation to the 2018/19 field trials of the PREtec peptide PHC279 for the

    Plant Health Care Plc

    Plant Health Group plc New Distribution Agreement for Harpin αß

    Plant Health Care plc (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced a new distribution agreement with Wilbur-Ellis Company LLC, a leading U.S. agriculture distributor, for exclusive access to

    Path Investments Plc

    Path Investments plc Update on Heads of Agreement

    Path Investments plc (LON: PATH) today provided an update regarding the Heads of Agreement with ARC Marlborough Pty Limited (“ARC”) in relation to the proposed acquisition of ARC by the Company (the “Proposed Transaction”) announced on

    Plant Health Care Plc

    Plant Health Care Made exciting progress in 2018

    Chris Richards, Plant Health Care Interim CEO, commented: “Plant Health Care continued to make exciting progress in 2018, in spite of recently announced set-backs. The launch of our new corn product in the US holds great

    Plant Health Care Plc

    Plant Health Care Plc ProAct® Wins Top Industry Award

    Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: “This award is recognition that Plant Health Care, as a science-based company, can bring new benefits to growers with low toxicity, biological products. We

    Plant Health Care Plc

    Plant Health Care to present at Mello London

    Plant Health Care (LON: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced that the Company will be presenting at the Mello London investor conference on Tuesday 27 November 2018